Malwina Niczke – Chmura
B2RLaw Jankowski Stroiński Zięba
Malwina has extensive experience in providing legal advice for business. The scope of her specialization includes life sciences & healthcare. She also has many years of experience in providing ongoing legal services to enterprises in the SME sector, conducting negotiations with domestic and foreign contractors, corporate matters and pharmaceutical and restructuring issues.
Life Sciences & Healthcare | Commercial Law | Trade & Distribution | FMCG, Food & Drink
Malwina specializes in life sciences & healthcare, from manufacturing and distribution issues, through product registration, to advertising law and regulation of clinical trials. In particular, she focuses on creating distribution structures in the pharmaceutical market, including foreign markets.
Malwina also has experience in the area of restructuring, including advising insolvent or threatened with insolvency debtors regarding the type of restructuring taken, as well as specific restructuring activities, advising creditors on insolvent debtors to protect the interests and minimize financial losses of creditors and supporting negotiations between debtors and creditors.
Corporate Advisory | Corporate & M&A
Malwina has many years of experience in legal advisory services to the SME sector. She has advised clients on the proper development of small and medium-sized enterprises, reorganization and entering foreign markets. Malwina has worked for Polish market leaders in the pharmaceutical and furniture industry, paints and consumer goods. She has also conducted a number of projects in close cooperation with foreign law firms (including in South Africa, China, Serbia and Macedonia). Malwina provides ongoing corporate advisory in the field of compliance, with particular attention to the issues related to transparency of internal and external processes, corporate governance and communication. She has participated in creating systems of internal procedures and codes of good practice. Malwina has also advised on a number of M&A transactions.